Multicenter retrospective study to examine the efficacy of intervention by healthcare providers for hand-foot skin reaction that occurred after sorafenib use for patients with advanced hepatocellular carcinoma
Not Applicable
- Conditions
- advanced hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000038701
- Lead Sponsor
- Hitachi General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria included the following: (1) A history of serious hypersensitivity to the components of this drug; (2) pregnant women or those who may be pregnant; (3) a history of thrombosis or ischemic heart disease; and (4) brain metastasis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method